Pervasis is a clinical stage company developing breakthrough therapies with the potential to improve outcomes following vascular procedures. Learn more
Our therapies build on the ability of the body's endothelium to regulate natural healing processes. Learn more
February 26, 2010
Mass High Tech 8th annual BioForum - "High risks, high rewards" panel presentation with Josh Hamermesh, Sr. Vice President, Pervasis.
February 1, 2010
Pervasis Therapeutics Receives FDA Clearance for Pivotal Phase 3 Trial of Vascugel ® [PDF]